|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 221.5 USD | -0.56% |
|
+1.83% | -14.40% |
| May. 09 | MOVES -Lazard hires veteran healthcare dealmaker Colocci as vice chairman | RE |
| May. 08 | Redburn Atlantic Adjusts Price Target on Biogen to $235 From $275, Keeps Neutral Rating | MT |
Biogen Inc. revenue was $3.68 billion, representing growth of 1.8%, compared with $3.62 billion of revenue in last year's second quarter.
'Biogen Records Better-Than-Expected 2Q Adj Profit, Rev' at 7:50 a.m. EDT on July 22 gave an incorrect quarter in the fourth paragraph.
| 1st Jan change | Capi. | |
|---|---|---|
| -14.40% | 32.25B | |
| -2.61% | 89.08B | |
| +3.55% | 40.9B | |
| +55.89% | 25.14B | |
| -15.96% | 15.39B | |
| -15.50% | 11.91B | |
| -41.29% | 11.89B | |
| -11.75% | 11.64B | |
| +7.87% | 9.03B | |
| -3.16% | 8.62B |
BIOGEN INC. 